NCT06891287 - An Early Phase Study of RT-114 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

April 1, 2026

Conditions

Obesity

Interventions

COMBINATION_PRODUCT

RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity

RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity.

DRUG

PG-102

PG-102 is a drug for the treatment of obesity.

OTHER

Placebo

The placebo is the RaniPill with saline instead of a drug.